Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,002 INR | +0.33% | +7.09% | +2.52% |
Apr. 26 | Weak March Quarter Earnings Weigh Down Indian Equities on Friday | MT |
Apr. 25 | Divi's Laboratories Plans Up To INR7 Billion Investment to Boost Capacity | MT |
Sales 2024 * | 76.83B 921M | Sales 2025 * | 88.65B 1.06B | Capitalization | 1,063B 12.73B |
---|---|---|---|---|---|
Net income 2024 * | 15.4B 185M | Net income 2025 * | 20.4B 244M | EV / Sales 2024 * | 13.2 x |
Net cash position 2024 * | 46.03B 552M | Net cash position 2025 * | 48.33B 579M | EV / Sales 2025 * | 11.4 x |
P/E ratio 2024 * |
68.7
x | P/E ratio 2025 * |
52
x | Employees | 8,433 |
Yield 2024 * |
0.66% | Yield 2025 * |
0.72% | Free-Float | 47.74% |
Latest transcript on Divi's Laboratories Limited
1 day | +0.33% | ||
1 week | +7.09% | ||
Current month | +16.17% | ||
1 month | +16.17% | ||
3 months | +12.09% | ||
6 months | +17.31% | ||
Current year | +2.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 01-08-09 | |
Founder | 73 | 90-10-11 | |
Director of Finance/CFO | 74 | 94-11-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 73 | 90-10-11 | |
Chief Executive Officer | 46 | 01-08-09 | |
Director/Board Member | - | 14-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.68% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 4,002 | +0.33% | 360,469 |
24-04-29 | 3,989 | -0.67% | 752,787 |
24-04-26 | 4,016 | +4.49% | 1,155,173 |
24-04-25 | 3,844 | +0.79% | 835,354 |
24-04-24 | 3,814 | +1.20% | 473,558 |
Delayed Quote NSE India S.E., April 30, 2024 at 07:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.52% | 12.69B | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- DIVISLAB Stock